舒芬太尼配伍异丙酚用于无痛纤支镜检查的临床研究

目的探讨舒芬太尼配伍异丙酚用于纤支镜检查的镇静、镇痛效果。方法将120例拟行纤支镜检查的患者,按入院顺序分为两组:S组(舒芬太尼 异丙酚,n=60)和F组(芬太尼 异丙酚,n=60)。术中监测心率(HR)、收缩压(SBP)、舒张压(DBP)和氧饱和度(SPO2),记录异丙酚用量、检查时间、苏醒时间、镇静评分等。结果与用药前比较,两组患者用药后3minHR较用药前均明显增快(P<0.05);两组患者用药后3minSPO2较用药前明显下降(P<0.05,P<0.01),但两组患者用药前后SBP、DBP差异无统计学意义(P>0.05)。两组患者组间比较,异丙酚用量、镇静评分相近,其差异无统计学意义(P>0.05);S组苏醒时间比F组短,差异有统计学意义(P<0.01)。结论舒芬太尼配伍异丙酚可以安全用于无痛纤支镜检查术。

Clinical Observation of Sufentanil Combined with Propofol for Painless Fiberbronchoscopy

Objective To assess the safety and efficacy of sufentanil combined with propofol for painless fiberbronchoscopy. Methods A total of 120 patients undergoing fiberbronchoscopy were divided into two groups according to their admission sequence: group S (sufentanil propofol, n=60) and group F (fentanil propofol, n=60). Parameters including heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), saturation of blood oxygen (SPO2), dose of propofol, duration of the procedure, waking time and score of Observer's Assessment of Alertness/Sedation (OAA/S) scale were recorded. Results The HR increased significantly 3 minutes after drug administration in both groups (P<0.05). The SPO2 decreased significantly 3 minutes after drug administration in both groups (P<0.05). The average dose of propofol and OAA/a score were similar between the two groups (P>0.05). The waking time was significantly shorter in group S than in group F (P<0.05). Conclusion Sufentanil combined with propofol could offer a good sedative/analgesic effect during painless fiberbronchoscopy.